LEADER 01247nam  2200301z- 450 
001 9910689704103321
005 20050308084708.0
035   $a(CKB)5860000000018922
035   $a(BIP)011941199
035   $a(EXLCZ)995860000000018922
100   $a20220406c2004uuuu  -u-         -
101 0 $aeng
200 10$aCervical cancer and human papillomavirus $ehearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, second session, March 11, 2004
215   $a1 online resource (iii, 588 p.) $cill
311   $a0-16-073743-5 
517   $aCervical cancer and human papillomavirus 
606   $aCervix uteri$xCancer$xEtiology
606   $aPapillomaviruses$xPathogenicity
610   $aPapillomaviruses
610   $aUterus
610   $aMedical
615  0$aCervix uteri$xCancer$xEtiology.
615  0$aPapillomaviruses$xPathogenicity.
712 02$aUnited States, Congress House Committee on Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources Staff,$4oth
906   $aBOOK
912   $a9910689704103321
996   $aCervical cancer and human papillomavirus$93126345
997   $aUNINA